• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-1285-3p 是人类骨肉瘤的一个潜在预后标志物,通过靶向 YAP1 发挥肿瘤抑制作用。

miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.

出版信息

Cancer Biomark. 2019;25(1):1-10. doi: 10.3233/CBM-180013.

DOI:10.3233/CBM-180013
PMID:31006663
Abstract

BACKGROUND

Despite the major advances in the treatment, the overall survival of osteosarcoma remains poor. MicroRNAs (miRNAs) are involved in tumorigenesis and progression though modulating their target genes. In the present study, the roles of miR-1285-3p in osteosarcoma was investigated.

METHODS

Microarray profiling was applied to distinguish the up and down regulated microRNAs in osteosarcoma. Quantitative real-time PCR (qRT-PCR) assay was performed to detect the expression of miR-1285-3p and YAP1 expression. MTT and transwell assays were carried out to determine the cells proliferation and invasion respectively. Moreover, dual luciferase reporter assay was performed to evaluate the binding efficiency between miR-1285-3p and the 3'UTR of YAP1.

RESULTS

MiR-1285-3p was down regulated in osteosarcoma tissues and cell lines and the reduction of miR-1285-3p expression predicted a poor overall survival of osteosarcoma patients. Ectopic expression of miR-1285-3p inhibited osteosarcoma cell proliferation, colony formation and invasion. In addition, YAP1 was further demonstrated as a direct target of miR-1285-3p. Moreover, overexpression of YAP1 reversed the inhibitory effects of miR-1285-3p on osteosarcoma cells proliferation and invasion.

CONCLUSIONS

MiR-1285-3p which was low expressed in osteosarcoma inhibited the proliferation and invasion of osteosarcoma cells via direct targeting YAP1. These results suggested that miR-1285-3p might be a potential therapeutic targets and biomarker in osteosarcoma.

摘要

背景

尽管在治疗方面取得了重大进展,但骨肉瘤的总体生存率仍然较差。 microRNAs(miRNAs)通过调节其靶基因参与肿瘤发生和进展。本研究探讨了 miR-1285-3p 在骨肉瘤中的作用。

方法

应用微阵列分析区分骨肉瘤中上调和下调的 microRNAs。通过定量实时 PCR(qRT-PCR)检测 miR-1285-3p 和 YAP1 表达。MTT 和 Transwell 测定分别用于测定细胞增殖和侵袭。此外,双荧光素酶报告基因测定用于评估 miR-1285-3p 与 YAP1 的 3'UTR 之间的结合效率。

结果

miR-1285-3p 在骨肉瘤组织和细胞系中下调,miR-1285-3p 表达的降低预示着骨肉瘤患者总体生存率较差。过表达 miR-1285-3p 抑制骨肉瘤细胞增殖、集落形成和侵袭。此外,进一步证实 YAP1 是 miR-1285-3p 的直接靶标。此外,过表达 YAP1 逆转了 miR-1285-3p 对骨肉瘤细胞增殖和侵袭的抑制作用。

结论

在骨肉瘤中低表达的 miR-1285-3p 通过直接靶向 YAP1 抑制骨肉瘤细胞的增殖和侵袭。这些结果表明,miR-1285-3p 可能是骨肉瘤的潜在治疗靶点和生物标志物。

相似文献

1
miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.miR-1285-3p 是人类骨肉瘤的一个潜在预后标志物,通过靶向 YAP1 发挥肿瘤抑制作用。
Cancer Biomark. 2019;25(1):1-10. doi: 10.3233/CBM-180013.
2
Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.长链非编码 RNA APTR 通过抑制 miR-132-3p 和上调 yes 相关蛋白 1 促进骨肉瘤的进展。
J Cell Physiol. 2019 Jun;234(6):8998-9007. doi: 10.1002/jcp.27572. Epub 2018 Oct 14.
3
MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.miR-384 通过调控 IGFBP3 抑制骨肉瘤的恶性生物学行为,如增殖和侵袭。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820909125. doi: 10.1177/1533033820909125.
4
Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.长链非编码 RNA XIST 通过靶向 miR-195-5p 促进骨肉瘤进展。
J Cell Biochem. 2018 Jul;119(7):5646-5656. doi: 10.1002/jcb.26743. Epub 2018 Mar 25.
5
MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.miR-127-3p 通过靶向 ITGA6 抑制人骨肉瘤细胞的生长和侵袭。
IUBMB Life. 2018 May;70(5):411-419. doi: 10.1002/iub.1710. Epub 2018 Mar 23.
6
MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.微小 RNA-338-3p 通过靶向 RUNX2/CDK4 和抑制 MAPK 通路抑制骨肉瘤细胞的肿瘤生长和转移。
J Cell Biochem. 2019 Apr;120(4):6420-6430. doi: 10.1002/jcb.27929. Epub 2018 Nov 28.
7
MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.miR-455-3p 下调促进骨肉瘤细胞增殖和侵袭并预测不良预后。
J Orthop Surg Res. 2020 Oct 2;15(1):454. doi: 10.1186/s13018-020-01967-1.
8
MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.miR-501-3p 通过靶向 BCL7A 促进骨肉瘤细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):624-633. doi: 10.1007/s13577-020-00468-x. Epub 2021 Jan 7.
9
Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.环状 RNA 0003998 通过与骨肉瘤中的 miR-197-3p 结合来促进细胞增殖能力和侵袭性。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10638-10646. doi: 10.26355/eurrev_201912_19761.
10
MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.微小RNA-330-3p的表达预示骨肉瘤预后良好,并通过靶向Bmi-1抑制细胞增殖。
Cell Physiol Biochem. 2018;46(2):442-450. doi: 10.1159/000488612. Epub 2018 Mar 26.

引用本文的文献

1
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.差异性miRNA和蛋白质表达揭示了miR-1285及其靶标TGM2和CDH-1,以及CD166和S100A13作为糖尿病和胰腺腺癌患者潜在的新型生物标志物。
Cancers (Basel). 2024 Jul 31;16(15):2726. doi: 10.3390/cancers16152726.
2
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.骨肉瘤生长中的信号通路和 microRNAs 以及间充质干细胞在致癌中的双重作用。
Int J Mol Sci. 2023 May 19;24(10):8993. doi: 10.3390/ijms24108993.
3
Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients.
骨旁骨肉瘤脂肪 CT 衰减值和体积预测儿童患者化疗反应的价值。
Clin Transl Oncol. 2023 Jun;25(6):1710-1718. doi: 10.1007/s12094-022-03068-3. Epub 2023 Jan 14.
4
The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.非编码 RNA 与 YAP/TAZ 信号通路在癌症中的相互作用:分子功能和机制。
J Exp Clin Cancer Res. 2022 Jun 14;41(1):202. doi: 10.1186/s13046-022-02403-4.
5
The functional activity of donor kidneys is negatively regulated by microribonucleic acid-451 in different perfusion methods to inhibit adenosine triphosphate metabolism and the proliferation of HK2 cells.供体肾脏的功能活性受不同灌注方法中小核糖核酸-451 的负调控,以抑制三磷酸腺苷代谢和 HK2 细胞的增殖。
Bioengineered. 2022 May;13(5):12706-12717. doi: 10.1080/21655979.2022.2068739.
6
Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial-mesenchymal transition in proliferative vitreoretinopathy.微小RNA-1285对Smad4的抑制作用可减轻转化生长因子-β诱导的增殖性玻璃体视网膜病变中的上皮-间质转化。
PLoS One. 2021 Aug 12;16(8):e0254873. doi: 10.1371/journal.pone.0254873. eCollection 2021.
7
Linc00467 promotes invasion and inhibits apoptosis of head and neck squamous cell carcinoma by regulating miR-1285-3p/TFAP2A.Linc00467通过调控miR-1285-3p/TFAP2A促进头颈部鳞状细胞癌的侵袭并抑制其凋亡。
Am J Transl Res. 2021 Jun 15;13(6):6248-6259. eCollection 2021.
8
miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.微小RNA-497通过Yes相关蛋白1(YAP1)抑制三阴性乳腺癌细胞的增殖和侵袭。
Oncol Lett. 2021 Aug;22(2):580. doi: 10.3892/ol.2021.12841. Epub 2021 Jun 2.
9
Allelic Expression Imbalance Analysis Identified Amplification in p53- Dependent Osteosarcoma.等位基因表达失衡分析确定了p53依赖型骨肉瘤中的扩增现象。
Cancers (Basel). 2021 Mar 18;13(6):1364. doi: 10.3390/cancers13061364.
10
TRPS1 and YAP1 Regulate Cell Proliferation and Drug Resistance of Osteosarcoma via Competitively Binding to the Target of circTADA2A - miR-129-5p.TRPS1和YAP1通过竞争性结合circTADA2A-miR-129-5p的靶标来调节骨肉瘤的细胞增殖和耐药性。
Onco Targets Ther. 2020 Dec 1;13:12397-12407. doi: 10.2147/OTT.S276953. eCollection 2020.